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Abstract
In higher eukaryotes, PAPS synthases are the only enzymes producing the essential sulphate-donor 39-phospho-adenosine-
59-phosphosulphate (PAPS). Recently, PAPS synthases have been associated with several genetic diseases and retroviral
infection. To improve our understanding of their pathobiological functions, we analysed the intracellular localisation of the
two human PAPS synthases, PAPSS1 and PAPSS2. For both enzymes, we observed pronounced heterogeneity in their
subcellular localisation. PAPSS1 was predominantly nuclear, whereas PAPSS2 localised mainly within the cytoplasm.
Treatment with the nuclear export inhibitor leptomycin B had little effect on their localisation. However, a mutagenesis
screen revealed an Arg-Arg motif at the kinase interface exhibiting export activity. Notably, both isoforms contain a
conserved N-terminal basic Lys-Lys-Xaa-Lys motif indispensable for their nuclear localisation. This nuclear localisation signal
was more efficient in PAPSS1 than in PAPSS2. The activities of the identified localisation signals were confirmed by
microinjection studies. Collectively, we describe unusual localisation signals of both PAPS synthase isoforms, mobile
enzymes capable of executing their function in the cytoplasm as well as in the nucleus.
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Introduction
Central to all biological sulphation reactions in eukaryotes is the
conversion of the very stable oxy-anion sulphate to the high-
energy sulphate donor 39-phospho-adenosine-59-phosphosulphate
(PAPS). Sulphation of a variety of biomolecules can be understood
as a high-affinity, low-capacity conjugation system where the
availability of the precursor PAPS is rate-limiting [1]. A vast
number of sulphotransferases has been described with 53 current
entries for human enzymes in Entrez Gene by now [2]. Part of this
enzymatic apparatus is required to create the highly complex
extracellular sulphated carbohydrates [3]. Other sulphotrans-
ferases are crucial for phase II detoxification of xenobiotics during
biotransformation [4].
The many and diverse sulphotransferases are localised to the
Golgi apparatus [5], the cytoplasm [6] and even the nucleus [7].
They are fed by only two PAPS producing enzymes in vertebrates
– the bifunctional PAPS synthases 1 and 2 (PAPSS1/2) [8,9]
consisting of an N-terminal adenosine-59-phosphosulphate (APS)
kinase domain and a C-terminal ATP sulphurylase domain
connected by a short irregular linker [10]. Lower animals seem
to have only one PAPS synthase gene, and this single enzyme is
essential at least for the worm Caenorhabditis elegans [11]. An
involvement of human and mouse PAPS synthase 2 in bone and
cartilage malformation is firmly established [9,12]. More recently,
PAPS synthases have also been implicated in steroid metabolism
[13] and hepatitis B infection [14].
P A P S S 1h a so n l yv e r yr e c e n t l yb e e nr e p o r t e dt op l a yay e t
undefined role in retroviral infection [15]. Using retroviral
insertion mutagenesis in CHO-K1 cells, a mutant cell line was
isolated with about 10fold reduction in infectivity by murine
leukaemia virus (MLV). This cell line had a mutation in the
PAPS synthase 1 gene and showed a defect in an intracellular
step of retroviral replication. Clearly, reduced HIV infection
rates were not due to reduced sulphation of the HIV co-receptor
CCR5 [16]. Within the nucleus, the requirement for PAPS was
mapped to a step during viral DNA integration into the host
genome that has a subsequent effect upon the level of expression
of viral genes. The exact nature of this PAPS-dependent process
is yet unknown, but it also affects gene transcription from the
long terminal repeat regions of human immunodeficiency virus
1 (HIV-1) [15].
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deficiencies were reported in the context of a wild-type gene for
the other PAPS synthase isoform. A major question at this point is
why the two isoforms cannot complement for each other. Both,
Bruce et al. [15] and Noordam et al. [13] referred at this point to
the different cellular localisation of the two proteins. There is only
one previous study on the localisation of PAPS synthases [17]
reporting human PAPSS1 as a nuclear protein. Besides, murine
PAPSS2 was also studied and was found to reside exclusively in the
cytoplasm in the absence of overexpressed PAPSS1. Upon co-
expression of PAPSS1, however, localisation of mouse PAPSS2
was shifted towards the nucleus [17]. Recent evidence revealed
that this process may occur via the formation of high-affinity PAPS
synthase heterodimers [18].
We show that sub-cellular localisation of the human PAPS
synthases is more intricate than reported previously. Although
both PAPSS synthase proteins are able to shuttle between nucleus
and cytosol, we could confirm a general trend of more nuclear
PAPSS1 and more cytosolic PAPSS2 protein in our study. Both
proteins were only marginally affected in their localisation after
prolonged treatment with the export inhibitor leptomycin B
pointing to an exportin1-independent export mechanism. By
mutagenesis, a positively charged a-helical segment within the
APS kinase domain of both proteins was identified that also
showed export activity in microinjection experiments. Finally, we
identified an N-terminal KKxK motif as a strong, active nuclear
localisation signal conserved in bi-functional PAPS synthases.
Results and Discussion
PAPS synthases show pronounced heterogeneity in their
sub-cellular localisation
Previously, it was reported that PAPS synthases differ in their
sub-cellular localisation [17]. However, when expressing fusions of
fluorescent proteins and PAPS synthases in HeLa cells, we
observed remarkable heterogeneity of localisation for both
enzymes (Figure 1A and B). Hence, we classified a large number
of cells into five categories according to the localisation of their
protein fluorescence. The five classes used in this study are
depicted in Figure 1C.
PAPSS1 is predominantly nuclear and PAPSS2 cytosolic
To test our scoring system and the robustness of the method,
several microscopic samples were prepared consecutively varying
different parameters. The general trend in all our experiments was
that PAPSS1-EGFP was predominantly located to the nucleus,
and more of the PAPSS2-EGFP fluorescence could be detected in
the cytosol. Evaluation of transiently transfected living and fixed
cells gave comparable results (Figure 1D). Hence, the following
investigations were performed on fixed microscopic samples.
Prolonged expression of the respective EGFP fusions (48 h vs.
24 h) resulted in a shift towards a more nuclear localisation for
both PAPSS1 and -S2 (Figure 1D). PAPSS2-EGFP was
additionally expressed for 72 hours, not resulting in any significant
further nuclear accumulation (data not shown). At this point, the
effect of the fusion protein was also tested. DsRedmono fusion
proteins of PAPSS1 and PAPSS2 showed comparable expression
levels to the EGFP proteins, but were shifted more towards the
cytoplasm (Information S1). Most of the subsequent experi-
ments were done using the EGFP vector background. To test for
cell line-specific effects, PAPS synthase fusion proteins were
additionally studied in HEK 293 and CHO cells. In these cell
lines, localisation did not differ largely from the pattern observed
in HeLa cells (Information S1). Under all conditions tested, both
PAPS synthases were found to a certain extent in the nucleus and
the cytoplasm. To test whether the heterogeneous cellular
localisation described here was an indirect effect of varying
expression levels of the EGFP fusion proteins, the total
fluorescence signal was determined as the product of one cell’s
area and its average fluorescent intensity for ensembles of
PAPSS1- and PAPSS2-EGFP expressing HeLa cells. No correla-
tion was observed between expression level and observed
localisation pattern (Figure 2). The molecular weights of
70 kDa for monomeric and, even more, 140 kDa for dimeric
PAPS synthase proteins preclude passive diffusion because of the
size exclusion limit of the nuclear pore complex at around 40 kDa.
Hence, the localisation pattern described here may indicate the
involvement of active nuclear transport processes.
Inhibition of CRM1-dependent nuclear export has little
effect on cellular localisation of both PAPS synthases
The majority of nuclear export is mediated by the nuclear
export factor exportin1/CRM1. This export receptor can be
specifically inhibited by the natural product leptomycin B (LMB).
Hence, we determined whether LMB changed the localisation
patterns for the PAPS synthase proteins. Nuclear localisation was
found to be moderately enhanced after prolonged LMB
incubation for both PAPS synthase proteins. Even though the
effects were relatively weak, and the shifts towards nuclear
localisation rather incomplete, the accumulation could not be
detected in untreated cells (Figure 3A and B). We additionally
determined the percentage of co-localisation of the green
fluorescence of the PAPS synthase-EGFP fusions with Hoechst
Figure 1. Localisation of PAPS synthase wild-type fusion
proteins. A and B, microscopic images of PAPSS1- and PAPSS2-EGFP
fusions. Transfected HeLa cells were fixed upon 24 h of fluorescent
protein expression. Within every sample, cells with varying protein
localisation could be observed. C, schematic for classifying localisation
of PAPS synthase fusion proteins and their mutants. D, localisation
pattern for PAPS synthase wild-type proteins with respect to the way of
fixation and the expression time. A total of 1026 cells for PAPSS1-EGFP
(P1) and 1942 cells for PAPSS2B-EGFP (P2) were evaluated, respectively,
in fixed HeLa cells after 24 hours of expression. For all other conditions
at least 200 cells were scored except PAPSS2-EGFP in living HeLa cells
(n=122). EGFP, enhanced green fluorescent protein.
doi:10.1371/journal.pone.0029559.g001
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unbiased computation-based approached (Figure 3C). Indeed,
the area of co-localised fluorescence relative to the EGFP signal
increased significantly upon LMB treatment for both PAPS
synthase proteins.
Nevertheless, a leucine-rich nuclear export signal (NES)
following the recently proposed consensus for Rev-class NESs
[19] was found within the sequence of PAPSS2 (Information
S1). The crystal structure 1X6V of full length PAPSS1 proves the
corresponding sequence motif to be surface exposed and in mainly
alpha-helical conformation (Information S1). In microinjection
experiments, we observed that fluorescent GST-GFP fusion
proteins containing the proposed NESs were slowly exported into
the cytoplasm (Information S1). The remarkably strong HIV-1
Rev NES was also assayed for comparison (see below). In
agreement with existing data [20], this motif caused significantly
stronger export activity than the leucine-rich motifs described
here. The addition of some hydrophobic sequence to the GST-
GFP transport substrate might have caused a direct interaction
with the FG repeats of the nuclear pores and thereby accelerated
nuclear pore passage slightly. Therefore, CRM1-dependent
nuclear export seems not to play a major role in determining
the cellular localisation of PAPS synthases.
A mutagenesis screen to identify potential NLS and NES
motifs
Next, we mutated putative localisation signals in PAPS synthase
1 and 2 followed by quantitative assessment of their patterns of
cellular localisation. As PAPS synthases do not reside exclusively in
the cytoplasm, and no classical nuclear localisation signals (NLS)
could be found, we targeted (I) patches of at least two arginine
and/or lysine residues as parts of putative NLS motifs that are (II)
clearly surface-exposed in the available crystal structure 1X6V of
PAPSS1 [10]. These criteria resulted in a total of 13 putative NLS
mutants of PAPS synthase-EGFP fusions. Moreover, we mutated
some residues of human PAPS synthase 2 to their murine
counterparts as a previous study has reported an exclusively
cytoplasmic murine PAPSS2 protein [17]. Leu252 and Leu254,
mentioned above, as well as Ile221 and Ile224 were also changed
to alanines to test their effect as putative NES motifs within the full
length proteins. All mutants were generated by site-directed
mutagenesis in the background of our PAPS synthase-EGFP
expression constructs, expressed in HeLa cells and scored for their
cellular localisation patterns (Figures 4A and B).
Remarkably, the most severe shifts in cellular localisation were
induced by the RR111,112AA and KK9,10AA mutations in
PAPSS1 (Figure 4C and D) as the following: RR111,112AA
resulted in a nearly complete nuclear accumulation of the PAPSS1-
EGFP fusion protein. The KK9,10AA led to the opposite effect.
That is why the respective mutants were further studied and
described in more detail below. The corresponding mutations in
PAPSS2 (RR101,102AA and KK6,8AA) showed similarly shifted
localisation patterns. Changing amino acids to their murine
counterparts (L396T and R334Q in PAPSS2; R339Q in PAPSS1)
had no effect on cellular localisation patterns of PAPS synthases.
Weakly decreased nuclear localisation was observed for the putative
NLS mutants RR333,334AA in PAPSS1 and RR328,329AA in
PAPSS2. Other mutants aimed at targeting NLS motifs resulted in
slightly increased nuclear localisation (KK175,176AA and R442A
Figure 2. Heterogeneity of localisation does not correlate with
PAPS synthase-EGFP expression levels. A, microscopic images of
fixed HeLa cells transfected with PAPSS1- and PAPSS2-EGFP fusion
plasmids were analysed on a single-cell level using ImageJ 1.45.
Therefore, cells were scored according to the schematic of Figure 1 and
cell borders were defined as regions of interest (ROI). Then, cell surface
as well as mean fluorescence intensity was measured separately for
each cell followed by background correction. B, using single cell
analysis, 147 cells were measured by for PAPSS1-EGFP and 150 for
PAPSS2-EGFP. The classification of these ensembles recapitulates the
heterogeneous localisation pattern for both PAPS synthases reported in
Figure 1. C, multiplication of cell area and mean fluorescence intensity
results in a dimension-less fluorescence. This value represents the total
fluorescence of each cell and is assumed to correlate with the
expression level of EGFP fusion proteins. For the three major classes
of each ensemble, fluorescence was plotted in a box-and-whisker plot.
No correlation between expression level/fluorescence and cellular
localisation could be derived.
doi:10.1371/journal.pone.0029559.g002
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II221,224AA in PAPSS2 also localised like the wild type, these
residues seemed not to belong to a functional export signal.
Mutating leucine residues L252 and L254 to alanines resulted in
slightly increased nuclear accumulation of PAPSS2. For the mutant
PAPSS2-EGFP fusion proteins that showed the largest shifts in
cellular localisation, we determined expression levels by western
blotting (Information S1). As these were found to be nearly
identical at similar rates of transfection, we concluded that their
strongly shifted cellular localisation patterns are direct effects of the
mutations and not indirect effects of protein expression levels. In
sum, our mutagenesis screen revealed a novel sequence motif
mediating export activity containing R111 and R112 in PAPSS1 as
well as the counteracting comparably strong NLS in the very N-
terminus containing K9 and K10 in PAPSS1.
Transport activity in a heterologous background: an a-
helical motif with export activity
The strong effect of mutants RR111,112AA in PAPSS1 and
RR101,102AA in PAPSS2, respectively, was a surprising finding
from our mutagenesis screen. These mutations were thought to
obliterate a putative NLS and, hence, expected to result in
increased cytoplasmic localisation of the respective EGFP fusions.
Though, the opposite was observed: In nearly all cells, PAPSS1-
EGFP RR111,112AA was exclusively found within the nucleus
(Figure 4C). In the dimeric crystal structure 1X6V of PAPSS1
[10], these residues are found within a long a-helix at the interface
of the two APS kinase domains. As both arginines and alanines are
known a-helix-promoting residues, NPS predictions [21] did not
point to markedly changed secondary structure for the double-
alanine mutant.
Figure 3. Effect of LMB treatment on PAPS synthase localisation. A, localisation patterns for PAPS synthase wild-type fusion proteins
following LMB treatment. HeLa cells expressing PAPSS1- and PAPSS2-EGFP fusion proteins were treated with the export inhibitor leptomycin B (LMB)
at a concentration of 10 nM for prolonged periods of time. At least 200 cells were visually evaluated per lane according to the scheme from figure 1.
B, examples of PAPSS1-EGFP expressing HeLa cells after 5 h LMB or mock treatment demonstrating increased nuclear accumulation caused by LMB.
C, alternative assessment of quantitative localisation after binarisation. Original images are shown before and after binarisation. In this instance, the
extracted parameters were: area of Hoechst fluorescence (16%), EGFP fluorescence (8.5%) and co-localisation (3.8%), co-localisation relative to
Hoechst (23%) and EGFP (44%) areas (ColocrelH and ColocrelE, respectively) as well as the ratio of EGFP and Hoechst areas (0.53) reflecting
transformation efficiency. The area of ColocrelE was found to be the most robust parameter for nuclear localisation of our PAPS synthase-EGFP fusion
proteins. D, effect of LMB treatment on PAPS synthase-EGFP fusion protein localisation measured according to C. The area of ColocrelE significantly
increases for both PAPSS1- and PAPSS2-EGFP proteins upon prolonged LMB treatment. *p values for unpaired two-tailed t-test relative to no LMB
treatment: PAPSS1-EGFP with 3 h LMB (0.034) and 5 h LMB (0.006) as well as for PAPSS2B-EGFP with 5 h LMB treatment (0.038).
doi:10.1371/journal.pone.0029559.g003
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promise formation of PAPS synthase dimers that are known to
have nano-molar affinity [18]. Subsequent exposure of unwanted
residues might interfere with proper cellular sorting. To test this
possibility, PAPSS1 wild-type protein and the respective mutant
RR111,112AA were expressed in a bacterial host and analysed for
their dimerisation behaviour by analytical gel filtration. L119K, a
second mutation within this long helix that enhanced nuclear
localisation of PAPSS1-EGFP, was tested in the same way. All
these PAPSS1 proteins clearly behaved like dimers in gel filtration
and their localisation was confirmed following binarisation
(Table 1). Of note, all proteins were loaded onto the column at
concentrations of 2-10 mM and are at most three-fold diluted
during the gel filtration run, indicating the KDs of all these
mutants still to be far below 1 mM.
Next, we studied the a-helical motif independent from full
length PAPS synthase proteins in a heterologous background of
recombinant GST-GFP proteins by microinjection experiments
[22]. The potential export signal was expressed as fusions with
glutathione S-transferase and GFP (GST-NES-GFP), purified and
injected into the nuclei of Vero cells, and transport was monitored
over time by live-cell fluorescence microscopy. There, the surface-
exposed helix surrounding Arg111 and Arg112 of PAPSS1
(Figure 5A and B) also showed NES activity independent from
the proteinous context of PAPS synthases, as the corresponding
helix-containing transport substrate was slowly, but quantitatively
exported into the cytoplasm (Figure 5C). As the tested 23 aa-
comprising sequence motif was highly conserved between the two
human PAPS synthases (91% sequence identity), these experi-
ments were solely performed with the peptide from PAPSS1. As a
control, GST-GFP was inactive under identical experimental
conditions, assuring that our system is not flawed by passive
diffusion (Figure 5C). The highly potent Rev NES was also
injected as positive control. Notably, the observed export activity
was completely abolished by replacing the same two arginine
residues by alanines (Helixmut, Figure 5A and C) that were also
mutated in our screen. This mutation made the a-helical transport
signal as inactive as the GST-GFP control under identical
experimental conditions.
The surrounding amino acid sequence of this helix could not be
matched to any leucine-rich NES type described so far, neither
PKI- nor Rev-type, and overall cellular localisation was only
marginally affected by treatment with the CRM1 inhibitor
leptomycin B. Several CRM1-independent NES sequences have
been reported [23–26], but there is no clear consensus amongst
them. Likewise, export of the human aci-reductone dioxygenase
(hADI1) via a non-canonical NES composed of multiple basic
amino-acid residues was not mediated via CRM-1 [27]. There,
substitution of the basic residues with alanines abolished NES
activity in the protein context of hADI1 similar to our observations
with PAPSS1. Basic residues contributing to nuclear export might
Figure 4. Mutation screen for localisation signals in PAPS
synthases. A and B, phenotype of all mutants evaluated in this study
for PAPSS1 and -S2. Potential NLS and NES signals were targeted by
alanine mutagenesis. This also included the putative NESs around
Ile221/Ile224 and Leu252/Leu254 in PAPSS2. At least 200 cells were
scored for each mutant. All mutants are arranged according to the sum
of the two fractions ‘‘nuc’’ and ‘‘n.c’’. *This mutant was evaluated in a
DsRedmono context due to very weak expression of the respective EGFP
fusion protein. Ca n dD , microscopic images of PAPSS1-EGFP
RR111,112AA as well as PAPSS1 KK9,10AA showing the strong and
nearly uniform phenotype of these two mutants.
doi:10.1371/journal.pone.0029559.g004
Table 1. Apparent molecular weight of PAPSS1 mutants.
PAPS synthase tested apparent Mw [kDa] co-localisation [%/EGFP]
PAPSS1 wild type 133 45.266.4
L119K 137 64.963.0
RR111,112AA 133 73.264.5
All proteins were loaded at a concentration of 2–10 mM on the gel filtration
column. Dilution during chromatography is three-fold at most. Co-localisation
was assessed after binarisation of images as described in the methods section.
doi:10.1371/journal.pone.0029559.t001
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[28], though the exact nuclear export signal for this export
receptor has not been definitively established [29].
The N-terminus of both PAPS synthases contains a highly
conserved KKxK motif
Our screen revealed strong phenotypes for mutating an N-
terminal KKxK motif both in PAPSS1 and -S2 that may constitute
a nuclear localisation signal (NLS). In agreement with this finding, it
has been shown previously that deletion of the N-terminal 21 amino
acids of PAPS synthase 1 abrogates nuclear localisation [17]. To
look at this motif in more detail, the N-termini of the human
proteins were aligned with the respective sequences of other PAPS
synthases (Figure 6A). Among these was PPS-1, the unique PAPS
synthase from the roundworm Caenorhabditis elegans that carries a
KKxR motif and has been described as nuclear protein [11].
On the contrary, an ectopically expressed mouse PAPSS2-
EGFP fusion was detected primarily in the cytosol [17]. In that
study, the coding sequence of AF052453 was used, which is
identical to the current RefSeq entry NM_011864.3. The encoded
protein (P2 mouse written in gray in Figure 6A) contains some
positively charged residues in the form of a KxxxKR motif, but
not the above mentioned KKxK motif. To compare this sequence
to more distantly related sequences, also the PAPS synthase
sequences from rat, medaka (Oryzias latipes) and the fruitfly
Drosophila melanogaster, all containing the KKxK motif, were added.
Is the mouse PAPSS2 sequence then an eminent exception? To
test this, we used the second exon of murine PAPSS2 to search the
mouse expressed sequence tag (EST) collection at NCBI using
BLASTn. A total of 15 EST sequences from various murine tissues
were retrieved that are listed in Table 2 together with their
encoded N-terminal protein sequence. Only one of these ESTs
(CA496923) supports RefSeq entry NM_011864.3. The other 14
Figure 5. A positively charged helical structure in PAPSS1 shows export activity. A, alignment of residues Ser102-Gly124 of PAPSS1 (P1)
and the respective Ser92-Gly114 sequence of PAPSS2 (P2). The two arginine residues targeted by alanine mutation are highlighted. NPS secondary
structure consensus prediction confirms an extended a-helical conformation; ‘‘.’’, coil; h/H, weak/prominent helical propensity. B, mapping of this
motif (cyan) on the interface of the APS kinase dimer within the PAPSS1 crystal structure 1X6V. The two arginine residues are shown in stick
representation (blue). Additionally, Glu108 is shown in stick representation (cyan). This residue may be necessary for charge compensation. C,a
recombinant GST-PAPSS1-Helix-GFP protein showed export activity upon microinjection into the nuclei of Vero cells at the indicated time points (left
panels). In contrast, mutation of two arginine residues completely abolished nuclear export (middle panel), and the respective substrate remained
nuclear as microinjected GST-GFP alone under the same experimental conditions (right panel). As a positive control, the Rev NES of HIV
(LQLPPLERLTL) was completely exported from the nucleus within 30 min following microinjection. Approximately 50 cells were injected, and
representative examples are shown.
doi:10.1371/journal.pone.0029559.g005
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the rat and human proteins (marked with an asterisk in
Figure 6A). Interestingly, the end of the variable N-terminal
stretch and the beginning of the conserved part of PAPS synthases
correlate with a conserved exon-exon border (Figure 6A) derived
from Ensembl. In agreement with this, both mRNA sequences
may result from regular splicing events: the sequence Besset and
colleagues [17] have used originates from an exon 13.7 kB
upstream of exon2. The new EST-supported variant would
require the removal by splicing of a 38 kB intron between this
sequence and exon2. Hence, the murine PAPS synthase 2 variant
investigated previously [17] may resemble our PAPSS2 KK6,8AA
mutant explaining the formerly described strong cytoplasmic
phenotype. Assuming the 15 retrieved ESTs in Table 2 represent
a quantitative picture of cellular transcript levels (in silico northern
blot), the resulting cytoplasmic protein is a minor isoform, and the
Figure 6. A conserved NLS within the N-terminus of PAPS synthases. A, alignment of the N-terminal protein sequence of PAPS synthases
from several organisms. PAPS synthase N-termini were aligned with regard to their conserved N-terminal KKxK motif and the beginning of the
conserved sequence of the globular APS kinase domain. Although this motif should be regarded as K(K/R)x(K/R) only due to the sequences from
fruitfly and worm, we adhere to KKxK in the text for simplicity. All positively charged amino acids are written in red and underlined. An exon-exon
border is indicated for all sequences derived from Ensembl. For mouse PAPS synthase 2 an alternative N-terminal sequence, P2 mouse*, is given that
is supported by 14 different EST sequences. The sequence for the swapping construct of the PAPSS1 N-terminal sequence and the remaining part
(body) of PAPSS2 is given below. Sequences used: human PAPSS1 (P1) [RefSeq: NM_005443], mouse P1 [RefSeq: NM_011863], rat P1 [RefSeq:
NM_001106471], medaka P1 [Ensembl: ENSORLP00000008587], splice form RA from Drosophila melanogaster [FlyBase: FBgn0020389], the PPS-1
protein from C. elegans [RefSeq: NM_069456/Wormbase: T14G10.1], medaka P2 [Ensembl: ENSORLG00000006251], rat P2 [RefSeq: NM_001106375],
mouse P2 [RefSeq: NM_011864.3], mouse P2* (Information S1) and human PAPSS2B [RefSeq: NM_001015880]. B, HeLa cells expressing PAPS
synthase point mutants within the conserved KKxK motif as EGFP fusions. All samples were fixed after 24 h expression. C, quantitative evaluation of
mutants shown in B and comparison to the wild-type proteins PAPSS1-EGFP and PAPSS2-EGFP. D and E, a swapping construct with the N-terminal
sequence of PAPSS1 and the PAPSS2-EGFP body expressed in HeLa cells shows clear nuclear accumulation relative to the PAPSS2-EGFP wild type.
doi:10.1371/journal.pone.0029559.g006
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more abundant mRNA species. Future research may show
whether an additional layer of regulated splicing contributes in
vivo to the intricate PAPS synthase localisation patterns described
here. For now, we conclude that a KKxK motif is remarkably
conserved in all aligned PAPS synthase N-terminal protein
sequences embedded within a variable sequence context.
Both human PAPS synthase isoforms were nearly completely
excluded from the nucleus (Figure 6B), when the above described
KKxK motif was mutated. Notably, nuclear exclusion seemed to
be slightly more pronounced for the PAPSS1-EGFP protein
(Figure 6C) indicating that the N-terminus of PAPSS1 may be
somewhat more effective in directing PAPS synthases to the
nucleus. Hence, we transferred this N-terminal segment of PAPS
synthase 1 to the body of the protein of PAPSS2-EGFP (the
resulting sequence P1N-term+P2body is also given in Figure 6A).
Clearly, nuclear localisation was enhanced for this protein chimera
relative to the parental PAPSS2-EGFP protein, but still less than
for PAPSS1-EGFP (Figure 6D and E).
To validate the activity of the proposed N-terminal nuclear
import sequence, we again applied microinjection of the KKxK
motif within the GST-GFP transport substrate system. There, we
analysed a short and an extended N-terminal peptide from human
PAPSS1 (Figure 7). Clearly, both constructs were imported into
the nuclei of Vero cells. The NLS of the T antigen of SV40 was
used as positive control and was imported even faster. An N-
terminal peptide derived from the coding sequence AF052453 of
murine PAPSS2 remained within the cytosol like the negative
control GST-GFP. However, an N-terminal peptide of an
alternatively spliced murine PAPSS2 supported by the ESTs listed
in Table 2 displayed import activity. In agreement with the
swapping construct described above, this signal was less potent in
nuclear import than its PAPSS1 counterpart.
The N-terminal 33 amino acids are disordered in the crystal
structure of the PAPSS1 full length protein [10]. In a recent
structure of the isolated APS kinase domain of the same protein,
nine additional amino acids are visible [30], still indicating the
flexibility of the remaining 24 N-terminal amino acids. This special
structural feature makes it unlikely that the N-terminal KKxK
motif belongs to a classical bipartite NLS [31] or even to the newly
described extended NLS [32,33], though the elongated PAPSS1-
NLS was slightly more active in microinjection experiments than
its shorter counterpart.
We conclude that the N-terminal KKxK motifs in both PAPS
synthases are functional nuclear localisation sequences. The
dimeric context of PAPS synthases may increase the efficacy of
this unusually short motif. Spacing and/or the exact nature of the
surrounding amino acids may tune the N-terminus of PAPSS1 to a
more effective nuclear localisation signal than the other, shorter
sequence of PAPSS2.
Conclusion
In the present study, we have characterised the localisation
signals that govern cellular distribution of PAPS synthases, the key
enzymes of biological sulphation reactions. Taking the molecular
weight of 140 kDa of the high affinity PAPS synthase dimers into
account [18], these enzymes seem to shuttle between cytoplasm
and the cellular nucleus using active transport mechanisms. We
have determined major localisation signals that influence cellular
localisation patterns of human PAPS synthase isoforms. Moreover,
we could derive relative strengths of the N-terminal KKxK NLS
Table 2. Supporting evidence for an alternative mouse PAPSS2 N-terminus.
Acc. No. mouse tissue (mRNA source) size [bp] encoded N-terminal protein sequence
EST sequences
BB599382.1 adult pancreas islet cells 262 MSGVKKQKK DQQKSTNVVYQAHHVSRNK
BF788130.1 kidney 935 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BP766402.1 pancreatic islet (C57BL/6) 514 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY038761.1 pooled tissues 372 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY039169.1 pooled tissues 473 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY039481.1 pooled tissues 357 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY048063.1 pooled tissues 371 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY050605.1 pooled tissues 383 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY057385.1 pooled tissues 345 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY224664.1 spleen lymphocyte 429 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY225041.1 spleen lymphocyte 392 MXGVKKQKT DQQKSTNVVYQAHHVSRNK
BY323396.1 synovial fibroblasts 336 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY331608.1 synovial fibroblasts 333 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
BY722941.1 adult female vagina 642 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
CA496923.1 kidney 834 MSANFKMNHKR DQQKSTNVVYQAHHVSRNK
cDNAs
AK137675 adult female vagina 2048 MSGVKKQKT DQQKSTNVVYQAHHVSRNK
AF052456.1 [9] 1996 MSANSKMNHKR DQQKSTNVVYQAHHVSRNK
BC090997.1 [41] 3652 MSANFKMNHKR DQQKSTNVVYQAHHVSRNK
The mouse EST database at GenBank was searched using BLASTN using the following exon2 sequence of murine PAPS synthase: gaccagcaaa aatccaccaa tgtggtctac
caggcccatc atgtgagcag gaacaagaga ggacaagtgg ttggaaccag gggaggattc cgaggatgta ccgtgtggct aaca.
All 15 hits are listed in this table. Moreover, the available cDNAs are listed. EST, expressed sequence tag.
doi:10.1371/journal.pone.0029559.t002
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NLS than its PAPSS2 counterpart. Furthermore, we could identify
a highly conserved Arg-Arg motif embedded within the a-helical
APS kinase domain interface mediating export capacity. This long
a-helical element around Arg111 and Arg112 in PAPSS1 is nearly
identical in the amino acid sequence to the respective sequence in
PAPSS2. Hence, this motif is expected to influence both enzyme
isoforms to a similar extent. Transient binding of some yet
unknown proteins or masking one of these counteracting signals by
post-translational modifications may be an efficient way to
adaptively relocate both PAPS synthases according to varying
cellular needs. Our analysis of signals that regulate nucleocyto-
plasmic shuttling of human PAPS synthases suggests that both
PAPSS isoforms need to be considered when addressing regulatory
functions of these PAPS producing enzymes within the nucleus or
the sulphation-dependent step in retroviral infection.
Materials and Methods
Plasmids and mutants
Coding sequences for human PAPS synthase 1 [RefSeq:
NM_005443] and PAPSS2B [NM_001015880] have been
described previously [10,18]. They were inserted via NheI/
BamHI into living colour vectors pEGFP-N1 and pDsRedmono-N1
[5]. Please refer to Information S1 for all primers used in this
study. The enhancer region of the CMV promoter in all pEGFP-
PAPSS2B constructs contained a 269 nucleotides-comprising
deletion that may be represented as partial cleavage with AatII
Figure 7. The KKxK motif shows import activity. Two peptide variants of the N-terminus of human PAPSS1 differing in length (long and short)
as well as the peptides encoded by the first exon of murine PAPSS2 were tested as GST-GFP transport substrates in microinjection experiments. A,
peptide sequences of the transport substrates tested. B, both recombinant GST-PAPSS1N-term-GFP proteins showed import activity upon
microinjection into the nuclei of Vero cells at the indicated time points (left panels). In contrast, an N-terminal peptide derived from murine PAPSS2
(mP2) remained cytosolic as microinjected GST-GFP alone under the same experimental conditions, whereas an N-terminal peptide of an alternatively
spliced murine PAPSS2 (mP2*) displayed weak import activity (middle panel). As a positive control, the nuclear localisation signal of the SV40 T-
antigen (SV40NLS) was completely imported into the nucleus within 60 min following microinjection (right panel). Approximately 50 cells were
injected, and representative examples are shown.
doi:10.1371/journal.pone.0029559.g007
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were prepared by site-directed mutagenesis with DpnI digestion
of the parental DNA (QuikChange kit, Stratagene, Agilent
Technologies, Waldbronn, Germany). A swapping construct with
the PAPSS1 N-terminus and the PAPSS2 body was generated by
first introducing an AclI site (AA‘CGTT) via silent mutations of
the Asn (aatRaaC) and Val codons (gtcRgtT) in both PAPS
synthase-EGFP fusion vectors (codons 27/28 and 17/18 in
PAPSS1 and -S2, respectively) followed by AclI/BamHI cloning
of the PAPSS2 body into the PAPSS1-EGFP fusion vector.
Potential localisation signals and domains were cloned into the
bacterial expression vector pGEX-GFP in between GST and GFP
by annealing of overlapping oligonucleotides comprising sticky
BamHI and NheI restriction sites as described [22]. All resulting
expression plasmids (Information S1) were verified by standard
DNA sequencing.
Cell culture, transfection, microinjection, and
fluorescence imaging of cells
The human epithelial carcinoma cell line HeLa (ATCC-No.
CCL-2), the human embryonic kidney cell line HEK293 cells
(ATCC CRL-1573), Chinese hamster ovary CHO cells (ATCC
CCL-61) as well as the monkey kidney cell line Vero (ATCC-No.
CRL-1587) were maintained as recommended by the American
Tissue Culture Collection (ATCC). HeLa cells grown on cover
slips as described [34] were transiently transfected with FUGENE
HD (Roche, Mannheim, Germany) according to the manufac-
turer’s instructions using plasmid DNA purified with the
NucleoBond Mini kit (Macherey-Nagel, Du ¨ren, Germany).
Nuclear DNA was co-stained with Hoechst 33258. Leptomycin
B (Alexis Biochemicals/Enzo Life Science, Lo ¨rrach, Germany)
was used at a concentration of 10 nM for the indicated number
of hours. Cover slips were fixed in 4% para-formaldehyde,
mounted with Mowiol 4–88 on microscope slides and sealed
using nail polish.
Fluorescent protein fusions of PAPS synthases were visually
classified into five categories. Therefore, blinded samples were
examined in each case. For all samples at least 200 cells were
scored, otherwise counted cell numbers (n) are indicated. Standard
deviations were between 6 and 8% when averaged over the three
largest fractions. These errors were derived from evaluating same
samples by the same individual on different days as well as same
samples counted by different persons.
In a complementary, unbiased computation-based approach,
quantitative localisation of EGFP fusion proteins was assessed after
binarisation. Therefore, original images acquired with a 106
objective were binarised within the cell‘P software (Olympus,
Mu ¨nster, Germany) as previously described [34]. A total of six
parameters was extracted from these images: area of Hoechst
fluorescence, EGFP fluorescence and co-localisation, co-localisa-
tion relative to Hoechst and EGFP areas as well as the ratio of
EGFP and Hoechst areas that reflects transformation efficiency.
The area of co-localisation relative to the EGFP fluorescence was
found to be a robust parameter for nuclear localisation of our
PAPS synthase-EGFP fusion proteins. Fluorescence intensity of
single cells was determined using ImageJ 1.45 s.
Purification and microinjection of recombinant GST-GFP
transport substrates in Vero cells were performed as described in
detail [22]. Observation, quantitation, image analysis and
presentation were performed as described [35].
Analytical gel filtration of PAPSS1 mutants
PAPS synthase 1 wild type and mutant proteins were expressed
in E. coli expression strains as fusions to GST-His6-PreScission as
previously described [18]. Site-directed mutagenesis was repeated
here with the same oligonucleotides used for mutagenesis in the
EGFP context. Proteins were purified on GSH sepharose. After
digestion with PreScission protease, pure PAPSS protein was
obtained on a Superdex 200 prep grade 26/60 (GE Healthcare,
Freiburg, Germany). Analytical gel filtration was then performed
on a Superdex 200 10/300 GL gel filtration column (GE
Healthcare, Freiburg, Germany) equilibrated in 20 mM Tris
(pH 7.3), 180 mM NaCl, 0.1 mM EDTA and 1 mM DTT that
was calibrated using thyroglobulin, ferritin, catalase, aldolase,
albumin and lysozyme.
Bioinformatics
Structural investigation of existing PDB files was performed
using YASARA [36]. Secondary structure predictions were done
using NPS [21]. Surface exposure of particular amino acids was
analysed using the DSSP tool [37] as described [18]. Sequences
were aligned using ClustalW [38]. The mouse EST collection at
GenBank was searched for using BLAST [39]. Genomic DNA
sequence for the murine PAPSS2 locus ENSMUSG00000024899
was retrieved from Ensembl [40] and searched for using the bl2seq
option of BLAST [39].
Supporting Information
Information S1 Cellular localisation of PAPS synthase
proteins. Localisation of different PAPS synthase fusion proteins
in several cell types. The influence of the nature of the fusion
protein (expressed in HeLa cells) as well as the cell line used was
assayed for PAPSS1 and PAPSS2 fusion proteins. At least 200 cells
were scored according to the schematic presented in Figure 1.
PAPS synthases contain a leucine-rich motif that acts as
weak NES. A, alignment of residues Leu254–Leu270 of PAPSS1
(P1) with the respective Leu244–Leu260 sequence of PAPSS2 (P2).
The short and long peptidic motifs tested for their nuclear export
activity are indicated. Residues of a putative leucine-rich NES are
written in bold. NPS secondary structure consensus prediction is
shown below the alignment; ‘‘.’’, coil; h/H, weak/prominent
helical propensity; ‘‘?’’, no prediction. B, mapping of this putative
leucine-rich export signal on one part of the ATP sulphurylase
domain of the PAPSS1 crystal structure 1X6V. The short
sequence is surface-exposed and shown in cyan, the extension in
blue. C, recombinant GST-PAPSS1/2-NES-GFP proteins con-
taining the respective leucine-rich signal sequences showed weak
export activity upon microinjection into the nuclei of Vero cells at
the indicated time points (left panels). In contrast, the GST-GFP
substrate remained nuclear under the same experimental condi-
tions (right panel). Approximately 50 cells were injected, and
representative images from live-cell fluorescence microscopy are
shown. D, due to the slow export kinetics of this motif it was not
possible to monitor completion of export within one round of the
cell cycle, therefore monitoring included mitotic nuclear envelope
breakdown and reassembly. Expression levels of PAPSS2-
EGFP wild-type and mutant proteins. Equal amounts of
HeLa cells were transfected with wild-type PAPSS2-EGFP
expression plasmid as well as those three mutants that showed
the largest shifts in cellular localisation: KK6,8AA, RR101,102AA
and LL252,254AA and expression levels were assessed by western
blotting using an anti-GFP antibody. Equal loading was shown
using an anti-tubulin antibody. All four fusion proteins showed
similar expression levels at comparable rates of transfection.
Additionally, detailed information on the plasmids and oligonu-
cleotides used in this study can be found within Information S1.
(PDF)
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